SMART Antiviral Prize: Teaming Forum
Interested in forming a team for the SMART Antiviral Prize? Join our Virtual Teaming Forum to connect with potential collaborators and start building strong, cross-disciplinary teams.
What to Expect:
Overview of the SMART Antiviral Prize and teaming opportunities
Lightning-style introductions highlighting participant capabilities and needs
Opportunities to identify potential collaborators across discipline
Guidance on how to connect and continue conversations after the session
Who Should Attend:
Researchers, biotechs, innovators, AI and drug discovery teams, and anyone interested in collaborating on broad-spectrum small molecule antiviral solutions.
This interactive session is designed to help you find the right partners and strengthen your approach to the prize.
A Zoom link will be provided to all registered participants prior to the call.
Teaming Presentations
If you’re a researcher, part of a biotech startup, or service provider working on broad-spectrum small molecule antivirals or support their development and would like to be considered for a teaming presentation, you can express interest here.
This is a unique chance to interact with other innovators and get yourselves noted. Teaming presentations will be held virtually during this event. Selected presenters will be provided details on format and duration prior to the event.
Please note: This does not register you for the event – attendance requires signing up through the Luma registration above.
BARDA Accelerator Network (BAN)
Established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), the BARDA Accelerator Network (BAN) fosters the growth of health security innovation ecosystems globally and accelerates the development and commercialization of next-generation health security solutions.
The BAN, comprised of 5 hubs, will serve as a global network supporting early-stage companies from around the world developing next-generation medical countermeasures (MCMs). The Hubs are focused on Diagnostics/Medical Devices, Therapeutics/Vaccines, Digital Health Tools, Special Populations, and Enabling Technologies.
VITAL is a BARDA Accelerator Network (BAN) Hub supporting the development and acceleration of next-generation therapeutic platforms and technologies to promote health security. It is led by Start2 Group in partnership with Advise Connect Inspire (ACI) and BioInnovation Labs (BioLabs). VITAL provides a global innovation network to enable impactful collaborations between the U.S. and other health security communities and their innovation ecosystems around the world.